Aktive Positionen von Lindsey Foulkes
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Arecor Ltd.
 Arecor Ltd. BiotechnologyHealth Technology Arecor Ltd. provides stabilization technology solutions. The firm's products include ultra-rapid acting prandial insulin, stable aqueous glucagon, ultra concentrated insulin and additional programs. The company was founded by Paul James Davis in 2007 and is headquartered in Cambridge, the United Kingdom. | Geschäftsführer | 01.01.2021 | - |
Karriereverlauf von Lindsey Foulkes
Ehemalige bekannte Positionen von Lindsey Foulkes
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| ARECOR THERAPEUTICS PLC | Geschäftsführer | 10.06.2021 | 02.11.2022 |
| CANGENE CORPORATION | Corporate Officer/Principal | - | - |
Liminal BioSciences Ltd.
 Liminal BioSciences Ltd. BiotechnologyHealth Technology Part of Liminal R & D BioSciences, Inc., Liminal BioSciences Ltd. is a British biopharmaceutical company founded in 2015. The company is based in Comberton, UK. The company is focused on the discovery and development of novel, small molecule drug candidates. | Corporate Officer/Principal | - | - |
Ausbildung von Lindsey Foulkes
| University of Glasgow | Doctorate Degree |
Statistik
International
| Vereinigtes Königreich | 5 |
| Kanada | 2 |
Operativ
| Chief Operating Officer | 2 |
| Corporate Officer/Principal | 2 |
| Doctorate Degree | 1 |
Sektoral
| Health Technology | 5 |
| Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| ARECOR THERAPEUTICS PLC | Health Technology |
| Private Unternehmen | 3 |
|---|---|
Cangene Corp.
 Cangene Corp. Pharmaceuticals: MajorHealth Technology Cangene Corp. developed, manufactured and sold biopharmaceutical drugs. The company was founded on February 22, 1984 and was headquartered in Winnipeg, Canada. | Health Technology |
Arecor Ltd.
Arecor Ltd. BiotechnologyHealth Technology Arecor Ltd. provides stabilization technology solutions. The firm's products include ultra-rapid acting prandial insulin, stable aqueous glucagon, ultra concentrated insulin and additional programs. The company was founded by Paul James Davis in 2007 and is headquartered in Cambridge, the United Kingdom. | Health Technology |
Liminal BioSciences Ltd.
Liminal BioSciences Ltd. BiotechnologyHealth Technology Part of Liminal R & D BioSciences, Inc., Liminal BioSciences Ltd. is a British biopharmaceutical company founded in 2015. The company is based in Comberton, UK. The company is focused on the discovery and development of novel, small molecule drug candidates. | Health Technology |
- Börse
- Insiders
- Lindsey Foulkes
- Erfahrung
